Uroxatral Articles

Alvogen launches new cancer generics in Romania; Mylan debuts Uroxatral copy in USA

15 August 2011

Sanofi-Aventis buys US market rights to AEterna Zentaris' cetrorelix for up to $165M

16 March 2009

Alfuzosin fails to improve prostatitis

12 January 2009

Sanofi-Aventis sales in Japan to double from 2005 to 2009

24 March 2008

Sanofi-Aventis' Uroxatral improves symptoms of BPH

6 June 2005

Sanofi's Uroxatral available in the USA

10 November 2003

France's Sanofi-Synthelabo announces New York stock listing

8 July 2002

Stock Commentary - Europe

25 October 2001

Stock Commentary - Europe

18 October 2001

UroXatral approvable, says US FDA

12 October 2001

Lorex's Xatral SR

27 November 1995

Showing 1-11 of 11 articles

Go to beginningPrevious
  • 1
NextGo to end